Clinical Trial Update: Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on monoclonal antibody-based sequential therapy aiming for deep remission in multiple myeloma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2023-11-22